Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].

Terapevticheskii arkhiv - 1 Jan 2013

Reshetniak T M, Ostriakova E V, Patrusheva N L, Patrushev L I, Aleksandrova E N, Seredavkina N V, Volkov A V, Nasonov E L

Abstract excerpt

AIM: To estimate the prevalence of plasminogen activator inhibitor type 1 (PAI-1) gene polymorphism in patients with antiphospholipid syndrome (APS) and its implication in vascular disorders. SUBJECTS AND METHODS: The investigation enrolled 138 patients: 103 with APS, including 47 with systemic lupus erythematosus (SLE) + APS and 56 with primary APS (PAPS), 15 with SLE without APS, 20 with idiopathic thrombosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiphospholipid Syndrome
Share to DNA

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Incidence

Share to Plasminogen Activator Inhibitor 1

Share to Promoter Regions, Genetic

Share to Real-Time Polymerase Chain Reaction

Share to Russia

Share to Thrombosis

Source

Identifiers

PMID: 23536951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].PMID 23536951Read ↗

The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndromeSemantic proximity Read ↗

[Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thrombosis in patients with antiphospholipid syndrome].Semantic proximity Read ↗

Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?Semantic proximity Read ↗

Genetic determinants of arterial thrombosis in primary antiphospholipid syndrome: a systematic review.Semantic proximity Read ↗

[PAL-1 5G/4G polymorphism in patients with systemic lupus erythematosus].Semantic proximity Read ↗

The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome.Semantic proximity Read ↗

CLINICAL AND GENETIC PECULIARITIES OF VASCULAR MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME (CASE REPORT).Semantic proximity Read ↗

[Antiphospholipid syndrome in the structure of hematogenic thrombophilia in young and middle-aged patients with venous thrombosis].Semantic proximity Read ↗

[Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus].Semantic proximity Read ↗

ANTIPHOSPHOLIPID SYNDROME AS A MODIFIER OF CLINICAL PHENOTYPES IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A CASE-CONTROL STUDY.Semantic proximity Read ↗

P-selectin glycoprotein ligand-1 VNTR polymorphisms and risk of thrombosis in the antiphospholipid syndrome.Semantic proximity Read ↗

Genetic risk factors of thrombosis in the antiphospholipid syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.